961P ICON7: ovarian cancer, platinum second-line chemotherapy and overall survival.
Authors
Cook, AEmbleton, A
Jayson, Gordon C
Kaplan, R
Kristensen, G
Parmar, M
Pfisterer, J
Pujade-Lauraine, E
Oza, A
Perren, T
Affiliation
MRC clinical trials unit, Institute of Clinical Trials and Methodology-UCL, LondonIssue Date
2017-09
Metadata
Show full item recordCitation
961P ICON7: ovarian cancer, platinum second-line chemotherapy and overall survival. 2017, 28(suppl_5): Ann OncolJournal
Annals of OncologyDOI
10.1093/annonc/mdx372.032Additional Links
http://academic.oup.com/annonc/article/doi/10.1093/annonc/mdx372.032/4109046/961PICON7-Ovarian-cancer-platinum-secondlineType
Meetings and ProceedingsLanguage
enISSN
0923-75341569-8041
ae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdx372.032